Poonam is currently a Team Lead within the Global Scientific Content group at Merck based in Kenilworth, NJ. She has global responsibility across the entire General Medicines portfolio with a large team covering key products. Most recently, Poonam was at Celgene in the Strategic Medical Communications and Innovation group. Prior to this, Poonam worked at Sanofi in the Medical Information Department for 12 years, at JNJ in the Global Competitive Intelligence group for 3 years, and at Parke-Davis in the MI Department for 3 years. She has 25 years of experience in Pharma and has 2 publications regarding Social Media and Medical Information Trends. Poonam chaired the 2019 DIA MASC meeting is now involved with DIA Annual.

David Bowers has 20+ years of experience managing pharmaceutical contact center programs at PPD. As Senior Director of Operations, David supports global medical information for pharmaceutical, biotechnology and medical device clients. He has a background in pharmacy, with a Doctorate of Pharmacy from the University of North Carolina in the United States. During his time at PPD, David has worked with over 30 client contact center programs providing medical information, pharmacovigilance and product complaint processing, patient adherence programs, REMS support and other services. David’s recent experience includes implementing contact center operations in the US, Europe, Latin America and Asia.

Alicia is Director and Team Lead for North America Oncology Medical Information at Pfizer Inc. Alicia has participated in the DIA Core Curriculum both as faculty and Chairperson, and in 2010 served as Chairperson for the DIA Annual March Med Comm Meeting. She has led the Fellow program for the DIA Med Comm Meeting from 2012 thru 2021. Alicia received her BS in Pharmacy from St. John’s University, and her PharmD from Albany College of Pharmacy. She spent 4 years at The University of Pittsburgh School of Pharmacy as a Nephrology Fellow and then as Assistant Professor of Pharmacy and Therapeutics. Alicia also worked in Medical Communications at Wyeth Pharmaceuticals and as Medical Director at CoMed Communications.

Ivy has 20+ years of experience in the pharmaceutical industry. She is a Principal Medical Information Lead at Genentech with experience across diverse therapeutic areas including Oncology, Rheumatology, Respiratory, Ophthalmology, Endocrinology, Neurology, Cardiovascular Disease, and various clinical conditions with an immunologic basis in pathophysiology. Prior to joining Genentech, she was a Clinical Pharmacist in General Surgery, Surgical Subspecialties, and Solid Organ Transplant at the University of California San Francisco (UCSF) Medical Center, and an Assistant Clinical Professor with the UCSF School of Pharmacy. Ivy received her PharmD from University of Tennessee Health Science Center.

Michael Church has been with Syneos Health for 15 years and working in the area of scientific communications for 19 years. Having started his career as a medical editor, Michael was a founding member of Syneos's clinical group and oversees a medical writing partnership that began with 5 associates in 2005 and has grown to its current state of 110 medical writers, editors, technical writers, and regulatory publishers. He is currently a Senior Director and leads the Syneos Strategic Resourcing Medical Writing Department.

Ed Cunningham, PharmD is Senior Director, Neurology Medical Science Liaison (MSL) Team Lead at Sunovion Pharmaceuticals Inc. Ed is based in Milwaukee, WI, and is responsible for overseeing the US Neurology MSL team. Prior to joining Sunovion, Ed was the Director of Specialty Care MSLs at Eisai Inc., leading the company’s Neuroscience and Metabolic MSL teams. Ed obtained his PharmD degree from Philadelphia College of Pharmacy and completed a 1-year Drug Information Residency with Janssen Pharmaceutica. Ed has been in the pharmaceutical industry for 17 years, working as a team leader in a variety of Medical Affairs functions, including Medical Information, Medical Education, Investigator Initiated Studies, and MSLs.

Dr. Gertel has more than 40 years of experience in the pharmaceutical industry in virtually all phases of pharmaceutical drug research and development, from preclinical pathology/toxicology to registrational clinical trials, post-marketing trials, project management, and market support. He has been involved in the development of standards in reporting clinical trial data, publications, and protocol development. He leads seminars and panels on drug development and bioethics.

Eileen M. Girten is Director of Medical Writing at Pfizer and is experienced in regulatory and publications writing, submissions, and mentoring. She is an Adjunct Assistant Professor at the University of the Sciences in Philadelphia and has taught Regulatory Documentation Processes for the Biomedical Writing program. Eileen earned a BA in Chemistry from Rosemont College, an MS in Psychology from Saint Joseph’s University, and an MS in Biomedical Writing from the University of the Sciences in Philadelphia.

In Craig’s more than 30 years working at Lilly, he has successfully worked in various positions in multiple therapeutic areas including neuroscience, diabetes and osteoporosis. Craig is a founding member of the Medical Science Liaison (MSL) program at Lilly where he worked in the New York City Metropolitan area for over 13 years in this field role. Craig spent 6 years as the MSL Trainer for Lilly USA and in 2017 became part of the Office of Medical Professional Development where is he assumed the role of the Global MSL trainer. Craig has been very active in developing benchmarking survey data on MSL standards across the pharmaceutical industry. Craig received the DIA Excellence in Service award in 2021.

Dr Marsh joined GSK on January 16, 2020 as the Director Medical Engagement and Communications. Most recently, she served at HEMA Biologics as the Director of Medical Affairs, Medical Information and Scientific Communication for HEMA Biologics, LLC from 2017-2020. Combining over 25 years of both clinical pharmacy and industry medical affairs experience, including 8+ years in leadership roles with globalization projects, Dr Marsh enjoyed working early in her career in ambulatory care and adult medicine inpatient settings, serving as adjunct faculty with Colleges of Pharmacy (UGA, USC, and Auburn). She began her career in industry GSK 19 years ago and since that time, continued opportunities working in a variety of medical affairs roles w

Robert Paarlberg is Principal of Paarlberg & Associates LLC, a consultancy specializing in regulatory policy, regulatory intelligence and global clinical trial disclosure strategy and operations. Prior to founding Paarlberg & Associates LLC, Bob worked at Pharmacia (Upjohn) and UCB. Bob is former Chair of DIA’s Clinical Trial Disclosure Community. Bob has more than 40 years of pharmaceutical industry experience with the vast majority of his experience in US and international regulatory affairs. Bob has been active in the clinical trial disclosure and transparency space since 2005.

Dr. Petses is the Medical Information Regional Lead for the Americas at Sanofi US. She is responsible for management and implementation of strategic and tactical medical information objectives across several business units. She has directed teams of medical information professionals who have provided support for products across broad therapeutic areas. She has managed the development of digital communication channels and a data mining tool to improve analytics and insights gathering. Prior to joining Sanofi she completed a Drug Information Residency at Schering-Plough. She earned her Bachelor and Doctor of Pharmacy degrees from St. John’s University in New York.

Rebecca Vermeulen, RPh, brings a variety of experiences to her role as VP of Strategy for Patients and Society, Product Development, at Hoffman La Roche. She has served in numerous functions including Medical Affairs, Clinical Research, Sales, Medical Communications, Medical Science Liaisons, Patient Partnership, Digital Health, and Six Sigma, in her 29 years of healthcare industry experience, and has been responsible for creating global standards for information exchange with healthcare professionals and patients. Rebecca is currently a board member for Patient Focused Medicines Development, Past Chair Board of Directors for the DIA, Chair Emeritus Corporate Board of Directors for the Healthcare Businesswomen’s Association.

Founder and president of Whitsell Innovations, Inc., a medical writing firm headquartered in Chapel Hill, NC, Ms. Whitsell has over 25 years of experience, specializing in global submission strategy, regulatory medical writing, emerging technologies, and data visualization. Prior to founding WI, Ms. Whitsell was the assistant director of preclinical & clinical development at Inspire Pharmaceuticals and a team lead at GlaxoWellcome. She has degrees in biophysics and physics from Miami University and interned at Los Alamos National Laboratory.

Kevin Appareti is Senior Director, Global Medical Science Liaison in the Chief Medical Office at Royal Philips. He leads the Key Opinion Leader Program and Medical Education Program. He works across Philips’ businesses, markets, and research to build strong internal and external relationships with Key Opinion Leaders (KOLs) and influencers. Kevin partners with internal business, market, and research leaders and external KOLs to develop Strategic KOL Engagement Programs to deliver strategic guidance, leverage clinical and scientific knowledge, foster peer-to-peer relationships, and support clinical and marketing evidence development and medical education in support of Philips development of meaningful innovations.

In her 25+ years of industry experience, Lynn has served in both individual and leadership positions within Medical Affairs at both large and start-up companies. She is currently Sr. Director, Medical Science Liaisons at BridgeBio, where she is building and leading a field medical team in the rare cardiovascular therapeutic area. Lynn is a transformative leader with proven excellence in building & developing high performing teams. Along with her leadership positions, Lynn is very active in growing/expanding the MSL profession across the industry and is a frequent invited speaker. She has also authored/ co-authored several MSL surveys highlighting and assessing the MSL role.

Geoff is Director, Global MSL Excellence with AstraZeneca Global Medical Affairs. In this role Geoff is responsible for ensuring the development and executon of MSL capabilities to AstraZeneca affiliates as well as the delivery and measurement of prioritized MSL Excellence initiatives. Previously Geoff was the MSL leader for AstraZeneca in Canada. Geoff has over 21 years of industry experience in a variety of roles across both Commercial and Medical functions.

Mike has over 15 years of industry Medical Information experience on the client side and vendor side, with a history of successfully setting the vison, strategy and leading the implementation of innovative contact center services. Over the past 10 years, Mike has focused on regionalizing and globalizing medical information, and as Vice President of Global Medical Information at ProPharma Group, Mike leads the Medical Information group globally. Mike is active in several professional organizations and is a frequent speaker at various industry conferences. Mike received a BS in Pharmacy from Temple University and earned his Doctor of Pharmacy from Shenandoah University.

Michelle Clausen is Senior Director and lead of the Pfizer Medical Strategy and Innovation Team which supports the Chief Medical Office at Pfizer. Michelle has 17 years experience in industry working across various roles within Medical Communications and now leads a team with a mission of driving strategy through innovation and insights to accelerate and advance the value of division’s contribution towards a healthier world. The team focuses on data & analytics, strategic communications, and innovative projects in collaboration with the groups they support. Michelle has her Doctor of Pharmacy (Shenandoah School of Pharmacy) and BS in Pharmacy (Rutgers College of Pharmacy).

Dr Liberti has worked in pharmaceutical regulatory affairs, communications and clinical R&D for the past four decades. From 2009 to 2021 he has served as the Executive Director of CIRS (the Centre for Innovation in Regulatory Science, Ltd, forming part of Clarivate Analytics). He has been actively involved in promulgating best practices in the regulatory aspects of medicines development, especially in the emerging markets. He received his doctorate in International Regulatory Policy through the WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht University, where his research centered on expedited regulatory pathways with applicability in the emerging markets. He is a volunteer with the nonprofit Erudee Foundation.

Steve received a PhD from MIT. He has held faculty appointments in electrical engineering at MIT, and in anesthesia and neurophysiology at Harvard Medical School and BWH. He founded Personal Health Technologies Corp. (PHT) in 1994 where serves as Chief Scientific Officer.

Mary is the Regional North America Lead for Pfizer Medical Information [MI]. Mary earned both a Bachelors and Doctorate degree in Pharmacy. Mary has greater than 20 years pharmaceutical industry experience specific to medical information. Outside of Pfizer, Mary is active in advancing the medical information profession through her leadership/collaboration roles in the Drug Information Association and phactMI [Pharma Collaboration for Transparent Medical Information]. Mary is currently serving on the phactMI board of directors for the term 2019-2020.

Jim Wilkinson, PhD is an executive leader in global and US Medical Affairs, with over 22 years in the biopharma industry. His experience includes leading Global/US Medical Information, Global Publications, Global/US Medical Communications, Global Field-Based Medical, and US Medical Science Liaison (MSL) teams. Jim has worked in multiple therapeutic areas while also launching multiple products throughout the course of his career. He has extensive working knowledge of the commercialization process, compliance, product launches, company/product acquisition and integration, legal and regulatory guidelines, operations, omnichannel communications, and promotional review. Jim received his B.S. from UW-Madison and his Ph.D. from UM-Minneapolis.

Pete Guillot is the president and founder of Centerfirst. Pete started Centerfirst in 2004 with the mission of helping pharma leaders make better decisions with insights derived from their contact centers. Centerfirst has worked with 11 of the top 20 bio-pharma companies and is a long term supporter of this DIA. Pete has an MBA from The University of Texas, and lives in Indianapolis, Indiana.

Darryl Z. L’Heureux is an active and engaged member of the medical writing community. Dr. L’Heureux received his PhD in Cancer Biology and Masters in Pharmacy, Quality Assurance and Regulatory Affairs from Temple University. He has worked within the NCI cooperative group structure and across small biotech to large pharmaceutical companies. Returning to his early research interest in immuno-oncology/tumor biology, he leads Integrated Oncology Lung Development at Bristol-Myers Squibb. Combining his interest in science and education, Dr. L’Heureux continues to present lectures/roundtables at professional and educational events. He teaches scientific writing in the Professional Master’s Scientific Writing Program at Temple University.

Dr. Nadal has over 30 years of experience in the Pharmaceutical Industry and has held positions of increasing responsibilities in Allergy and Pulmonary Clinical Research at Boehringer Ingelheim and Astra USA Pharmaceuticals. Dr. Nadal joined Bayer Healthcare Pharmaceuticals 20 years ago where he has led the Medical Information and Communications group. In his role he manages the Bayer Medical Information and Communications groups, the Medical Affairs Governance and Innovation groups, as well as the Bayer / Rutgers Medical Affairs PharmD and MD Fellowship program. Dr. Nadal is an active member of the Drug Information Association and was one recipients of the 2016 PhRMA “We Work For Health Champions”.

Dr. Raleigh Malik is a Sr. Scientist at DIA in Washington, DC, where she supports the advancement of DIA’s global content strategy by providing scientific expertise related to therapeutic drug development and regulatory disciplines. Prior to joining DIA, Dr. Malik supported medical and commercialization functions within pharma as both a medical writer and medical reviewer. Dr. Malik has a PhD in Molecular Biology and Biochemistry from Indiana University School of Medicine and a BS in Cell Biology and Biochemistry from Bucknell University.

Suz Schrandt, JD, is Patient Engagement Director at the Arthritis Foundation. She was previously Deputy Director, Patient Engagement for PCORI, where she helped to launch key efforts including the Engagement Rubric. Schrandt's patient engagement focus stems from her own rheumatological diagnosis at age 14. Prior posts include roles in health and disability law and policy, genetics, and public health. Schrandt is chair of the ISPOR Patient Roundtable and a member of the FDA’s PEAC.

Lisa Cesario graduated with a degree in Pharmacy from UofT. She was an oncology hospital pharmacist in Toronto and a member of the QA Committee with the NCIC CTG. Lisa joined Roche in 1998 and held various positions in Medical Information and Drug Safety. She joined Medical Affairs in 2008 and as a country medical manager for breast cancer. In 2012, Lisa became the Director of the MSL team across oncology. Lisa currently represents Roche on the Canadian Field Based MSL Forum.

Dr. DeWyngaert trained as a molecular biologist and has been actively involved in both research and business development roles for over 30 years. He has provided operational, clinical, managerial, consulting, and litigation services to various segments of the health care industry. He specializes in assisting pharmaceutical manufacturers, biotechnology, and medical device companies with identifying and mitigating regulatory risks, valuing intellectual property and litigation support.

Medical Information within the Pharmaceutical Industry for over 15 years. Currently working on the Sanofi US MI team, responsible for MI support and strategy for the Diabetes insulin product portfolio including standard response development and review, compendia review and submission, AMCP dossier development, insight generation and metric reports. Other teams/groups I am active with include: Sanofi Global Medical Information with a focus on global content and insights and analytics; Sanofi Patient Engagement Working Group; PhactMI Standards Subteam. Education: Graduate of the University of Connecticut School of Pharmacy Undegraduate Program, Idaho State University College of Pharmacy Doctor of Pharmacy Program.

Rania Gaspo earned her Pharmacy Degree and her PhD at University of Montreal, Faculty of Pharmacy. She served as a Post-Doctoral fellow at Montreal Heart Institute before moving into industry in 1998 as a Senior Scientist. Rania joined Pfizer in 2003 where she held positions in medical information, medical affairs and clinical development in various therapeutic areas. She also served as a guest speaker for 24 years at University of Montreal. In her current role Rania leads a team of Experienced Medical Information Managers within Neuroscience and Pain category leadership in US and Canada and Globally. Rania authored/co-authored about 25 peer-reviewed publications and 50 scientific communications.

Dr. Kulkarni is Principal Attorney for the Kulkarni Law Firm which focuses on providing legal and regulatory solutions to pharmaceutical companies and their providers. He is a pharmacist & lawyer and advises clients on bringing their product to market, focusing on post IND thru commercialization and genericization.

David Price, PhD has been employed with Eli Lilly and Company since 2011. David began as a Psychiatry Medical Science Liaison. David took the opportunity to diversify his MSL experience by transitioning to MSL roles supporting Urology as well as Musculoskeletal therapeutic areas. In 2014, David shifted to US Field Medical Operations and capability development across numerous therapeutic areas and MSL teams. Prior to his current role, David was a Global MSL Trainer in Lilly’s Office of Medical Professional Development. In 2018, David started his current position as a Field Medical Advisor providing operational leadership, strategic oversight and chief of staff responsibilities for Lilly’s US Bio-Medicines MSL program.

Holli has worked in the Center for 15 years with responsibilities focused on customer experience, operations, training, monitoring, and quality systems. She is motivated to drive positive customer experiences while managing the operations and regulatory needs for the business. Holli uses customer input to drive operational efficiencies and continuous improvement with business partners such as brands, medical, quality, safety functions. She is actively involved in the management, leadership and partnership with TLAC’s outsourced supplier relationship to deliver on The Lilly Answers Center experience. Holli graduated from Indiana University with Spanish/Political Science degrees and completed her Masters in Instructional Systems Technology.

Richard Swank is the former head of US Field Medical and Global Field Medical Excellence at Amgen and Founder of Scientific Engagement LLC. He has spent most of his career building medical capabilities in Medical Affairs, including building and managing MSL teams, managing medical information call centers, and improving how medical teams execute and measure field medical performance. He has a PhD in Biochemistry and Molecular Biology and prior to joining industry completed an NIH Postdoctoral Fellowship and was a senior fellow in Medical Genetics at the University of Washington.

Tom’s first role was with Wyeth in Pharmacovigilance and then as a Medical Science Liaison. He transitioned to Centocor Ortho Biotech as a Clinical Science Liaison Manager in Oncology and then moved into a Medical Information leadership and management role. In 2008 he joined Shire Pharmaceuticals where he led a national team of MSLs before becoming Director of Medical Communications. While at Shire, Tom assumed the Head of Global Medical Information and was responsible for the globalization of the function. Last year, Tom joined Sanofi as Associate Vice President, Medical Affairs and Head Medical Information.

Rebecca Williams, PharmD, MPH, is a Clinical Trials Subject Matter Expert with Essex, Part of Emmes Group. In this role she supports strategic policy and data initiatives with the National Cancer Institute’s Coordinating Center for Clinical Trials. Prior to this role she was the Acting Director of ClinicalTrials.gov at the National Library of Medicine (NLM) after having served as the Assistant Director for over a decade. She has also worked in regulatory and policy aspects of prescription drug advertising and promotion at the Food and Drug Administration and as a consultant. She received her Pharm.D. from the University of Wisconsin-Madison and MPH from Johns Hopkins Bloomberg School of Public Health.

Dominick Albano is Vice President, Global Medical Information at Pfizer. He is actively involved in phactMI. He began his industry career at Wyeth Pharmaceuticals as a Drug Information Manager specializing in the neuroscience therapy area. He held positions of increasing leadership and responsibility within Wyeth Global Medical Affairs. During his tenure he oversaw the implementation of a Neuroscience Medical Science Liaison (MSL) group, a Global Medical Communications Neuroscience Collaborative, and a Global Medical Information Leadership Council. Dr. Albano obtained his PharmD degree from the University of the Sciences in Philadelphia and his MBA in Healthcare Administration from Saint Joseph’s University in Philadelphia.

Dr. Anne Arvizu is founder and CEO of RxER Communications Corp (www.rxercommunications.com). With 22 years of executive leadership experience in the pharma/biotech industry, she has served in key roles such as Head of Global Med Info, Knowledge Mgmt. and Literature Surveillance for Baxter, Baxalta & Shire; Member Executive, PhactMI; International Regional Head & Director of Med Comm/Med Info for GSK, LATAM; DIA MASC Program Committee & Track Chair; Podcast Host for ACMA (#V3Podcast); Board Member of AMWA and serves as Chair, South Florida YMCA Board of Directors. She currently engages biotech C-Suite and VP Level executive clients as an expert consultant for Medical Affairs Capabilities build, renovation, and value-based business expansion.

Helle manages Medical Affairs writing, with a staff of Regional Leads and is responsible for special projects. She joined Johnson & Johnson, former Janssen Research Foundation (JRF), in 1997 and was closely involved in developing JRF’s first electronic submission. She led the oncology writing group and assumed early development MW for global Research units. She worked in the CDISC Glossary Group and in the standards developing organizations of HL7/RCRIM/CDISC Working Group for the Protocol Representation Model. She represented PhRMA on the ICH E3 Q&A Implementation Working Group. She’s a member of the TransCelerate Transparency Leadership Team, is the CSR Redaction Sub Team Co-Lead, and has 40+ years in the pharmaceutical industry.

In her role, she provides counsel regarding various issues including healthcare regulation, FDA advertising and promotion laws, Lanham Act. Jamie provides legal support to the company on general antitrust matters and is a core participant in several industry groups including PhRMA and the MIWG. Jamie also serves on the Lilly Diabetes executive team and the General Counsel’s staff. Prior to her current role, Jamie served as Assistant Secretary and Corporate Securities Counsel for Lilly, where she worked with the Eli Lilly executive committee and board of directors. Before coming to Lilly, Jamie was an associate at Sidley Austin LLP in Chicago, IL. She is a graduate of DePaul University College of Law, and Purdue University.

Debra has been with Eli Lilly & Company since 2001 and is currently Director of the Global Medical Affairs Centre of Excellence, Medical Liaison, Medical Education, and Medical Affairs Professionals. Debra joined the global medical affairs team in July 2013 as Director of Global Medical Liaison Capabilities and Development. The rest of her career at Lilly was within the Canadian affiliate most recently as Director of the Canadian medical liaison & medical education teams.

Arlene Kray has over 10 years of industry experience with increasing levels of responsibility. She received her PhD in Pharmacology from Vanderbilt University. She completed Post-doctoral Training at Carnegie Mellon University and then pursued a PharmD at Duquesne University while working as a clinical scientist and medical writer. She has been with PRA since 2016 and currently leads a team of medical writers and managers supporting Oncology. She also teaches Pharmacology to Nursing Students at the local community college.

Deniz Namarasli is a Senior Global Medical Information Leader at Roche. She is a medical doctor by training and has 12 years of Pharmaceutical Industry experience. She worked in different positions within Medical Affairs at local, regional and global level; which include Regional Medical Information Leader (EEMEA/CEMAI), Medical Manager, Medical Quality and Training Manager and Clinical Research Executive.

Jean Paty is a leader in effective strategies and practices of capturing patient experience data for use in clinical development and commercial success of new and existing medical products. Jean has been published extensively in the areas of Clinical Outcome Assessments (COA) and electronic COA (eCOA). He has deep expertise regarding regulatory guidance for development and implementation of eCOA, in addition to scientific, clinical, regulatory implications of COA data collection in clinical trials. Jean joined IQVIA in 2014 and has held a variety of leadership positions within the company.

Kim Pepitone, BA, CMPP, Scientific Director, Cactus Communications, provides professional training for CACTUS staff worldwide on best practices in medical publications. Kim has both authored articles and presented at many professional organizations' annual meetings on the topic, and has taught a graduate level course on publication planning at the University of the Sciences in Philadelphia. She is currently Vice Chair of the ISMPP Sunshine Act Task Force.

Michael Pietrack is the Pharmaceutical Industry's leading third-party recruiter. Michael heads up TMAC Direct, an executive search firm is the direct-hire capability of The Medical Affairs Company. TMAC Direct fills critical hires in Medical Affairs and Clinical Development with a specialty in field Medical Affairs and Physician Recruitment. Michael has made a name for himself not only in the Pharmaceutical Industry but in the Recruiting Industry as well. In 2013, he was named the #1 Worldwide Recruiter, and in 2015, he became a member of The Pinnacle Society, which is a group of 80 of the top recruiters in the world. Because of his level of success, Michael is a sought after speaker in both industries.

Dr. Jennifer Riggins has extensive experience in medical affairs, medical information, medical communications, and digital channels. She is the President of JSR Medical Affairs Consulting and also serves as the Partnership and Technology Strategist for phactMI, a non-profit organization that is both an industry Medical Information center of excellence and the single source of industry medical information. Dr. Riggins, a DIA Fellow, has served on the DIA Board of Directors and Advisory Council of North America among other activities. A dedicated PharmD student preceptor and former director of drug information residency and fellowship programs, Dr. Riggins earned her Doctor of Pharmacy degree from Butler University.

Kate graduated with a 2i BSc (Hons) in Biochemistry and a Phd in Pharmacology from the University of Southampton, UK. She spent her early career working as a headhunter and directing operations for a financial recuitment consultancy before joining the life sciences industry. Her 19 years in pharmaceuticals includes positions at AstraZeneca, Biogen and Shire (now Takeda - before joining Arena Pharmaceuticals in 2019. Roles have included commercial, medical, operations, and learning & development and many years working with MSLs - which is her passion. In her current position at Arena, she leads the International Field Based Medical Team, a hand-picked team with a laser focus on ensuring successful study enrolment.

Edward Brauer received his PharmD degree from the University of Southern California in 2015 and received his undergraduate degree in Chemistry from Fresno State in 2010. Currently Edward is a US MSL/RML Strategy and Capabilities Fellow within the US Medical Affairs department at Eli Lilly & Company. He currently has responsibility for Neurodegeneration/Pain and Dermatology MSL teams, where he also supports the teams as an internal liaison to the business.

Zachary has over 20 years of experience at Pfizer, and currently serves as the Director, Team Leader of the Analytics and Reporting group within the company’s Medical Division. In this role he oversees the analytics and reporting activities on behalf of several external-facing functions of the business, such as Medical Information, Publications and Clinical Trial Disclosure, developing innovative and effective data solutions for these internal customers.

Jennie G. Jacobson is President of Jacobson Medical Writing. She earned her BA from Swarthmore College, and PhD from Harvard University. Jennie was a post-doc at Upjohn Laboratories and the University of Michigan before realizing being a medical writer would allow her all the fun of interpreting data without having to generate it. She rounded out her education with two AMWA certificates, a certificate in Medical Writing from U Chicago, and CMPP certification. In her 24 years as a medical writer, Jennie has written publications in a wide array of therapeutic areas including oncology, neurology, health outcomes research, gene therapy, endocrinology, respiratory disease, autoimmune disease, ophthalmology, and gastrointestinal disease.

John Kamp is the Executive Director of the Coalition for Healthcare Communication, comprised of medical marketing agencies, medical mass media and medical journals. The CHC believes that truthful communication about medical products and services advances the public health.

Chris received his BS in Pharmacy from Rutgers University, and his PharmD from the University of Texas at Austin. He completed a Pharmacy Practice Residency at The University of Vermont Medical Center, and a Drug Information Specialty Residency with Lilly and Purdue University. Chris has spent the past 23 years at Eli Lilly and Company, working in various roles including Medical Information, Medical Liaison (Critical Care and Oncology), and Outcomes Liaison (National Accounts). Chris has presented and published on various topics including Literature Searching, Pharmacy Student Clerkships, Industry Liaison Practices, and Health Outcomes.

Jeff is the Director of US Medical Information at Gilead Sciences, where he is responsibility for developing and executing strategies to deliver medical information services across all Gilead products in the US. He has nearly 14 years of Medical Communications experience with roles in Scientific Communications, Publication Planning, and Medical Information at Eli Lilly, Sunovion Pharmaceuticals, and Vertex Pharmaceuticals. He holds a Masters of Public Health in Epidemiology from Indiana University and is a Certified Medical Publication Professional (CMPP).

Ann Winter-Vann earned her PhD in Molecular Cancer Biology from Duke University, where she was a predoctoral fellow of the Howard Hughes Medical Institute. Following a postdoctoral position in the Pharmacology Department at UNC-Chapel Hill, Ann joined Whitsell Innovations, Inc., where she is now a senior writer and manager. She has extensive experience in clinical regulatory writing and also provides consultations and training in medical writing. Ann has co-taught a science writing course for first-year biomedical graduate students at UNC-Chapel Hill. Ann is a past president of the Carolinas chapter and the current President of the American Medical Writers Association (AMWA).

Alan counsels clients and represents them at the FDA and in Congress on many of the critical issues that affect the pharmaceutical industry. He is a recognized expert on the Hatch-Waxman Act and lifecycle management, and is co-author of The Legislative History of the Drug Price Competition and Patent Term Restoration Act. Alan also has extensive experience in biological products, including the new biosimilars legislation, in food additive approvals, orphan drugs, and in over the counter drugs and the procedures used to switch them from prescription to non-prescription status.

Paul Grant has been involved in digital media since the inception of the public Internet. For much of the past 11 years, he has been based in London U.K., where he produced digital engagement strategies and social media insights for the leading health and pharmaceutical organizations in the world. Until his return to Australia, he was faculty lecturer in social media for the European Center of Pharmaceutical Medicine, an advisor in pharmaceutical guidance for digital communications, and Chief Innovation Officer for a global health consultancy. Paul is passionate about inspiring and motivating organizations towards an empowered and sustainable future capability.

Sabine Lischka-Wittmann, PhD is currently the European Medical Information Director for Eli Lilly & Company. She was previously the Senior Manager of the Medical Information and Medical Liaisons teams in Germany. Sabine is a highly experienced Medical Information manager: she has managed the German team for over 20 years. Sabine has lead numerous projects across the European region during her role as a European MedInfo Coordinator, including the implementation of Virtual MedInfo Teams in Europe to increase productivity, a quality assurance system for MedInfo responses, and the harmonization of process flows in this function. Sabine has presented at the DIA US Medical Communications workshop as well as the European Med Info conference.

In 2015, Kendra Bolt joined Audentes Therapeutics as the second member of it's Scientific Communications and Medical Affairs departments. Based in San Francisco, Audentes is now a clinical stage biotechnology company of nearly 200 employees, focused on manufacturing, developing, and commercializing gene therapy products for patients living with serious, life-threatening, rare diseases. Kendra's background is in intraoperative electrophysiological neuromonitoring, the systemic and computational biology of complex human disease, and rare disease drug development.